OPFOR.ai
Request demo

Forecast the trial. Supply the world.

Adaptive designs, global depots, shifting enrollment. OPFOR builds supply strategies that hold under pressure without a single manual spreadsheet update.

Request a demo

We build your entire portfolio for you. 25% less expired drug than your current plan. Guaranteed.

Coverage01All lots and transfers
Cross-study aggregation
Long range portfolio plans
Turn-key02We build your model
Live in days
Zero lift for your team
Unlimited03Seats and protocols
Scenario runs
No per-study fees
Guaranteed0425% less expiry
vs. plan of record
Every visit covered
01 / 03

Capabilities

Five instruments.
One forecasting engine.

001 Demand Forecasting Kit-level demand resolved per protocol, arm, and visit schedule, not per quarter, per patient-visit. ±0.4% / cohort
002 Scenario Simulation Enrollment curves, titration branches, and dropout rates simulated in thousands of Monte Carlo runs before first shipment. 10,000 runs / min
003 Depot & Distribution Global depot network planning with lane-level lead times, customs buffers, and cold-chain constraints built in. 38 countries
004 Expiry & Wastage Shelf-life-aware allocation that ships the right lot to the right depot. Overage cut without touching continuity. lot-level expiry
005 Actuals Reforecast IRT reports transmit planned vs. actual data, modeling it into a continuously updated real-time forecast. 24 h cycle
02 / 03

Method

Three phases.
The timetable holds.

1

Configure

Enter protocol assumptions: arms, visit schedules, titration logic, kit definitions, depot lanes. The trial becomes a formal supply model in minutes, not months.

Protocol → Model
2

Forecast

Simulate enrollment, dropout, and demand across thousands of scenarios. Output: a production and distribution plan with quantified confidence bands.

Model → Plan
3

Act

Live study actuals drives daily reforecasts. Orders, transfers, and lot allocations adjust before deviation becomes disruption.

Plan → Supply
03 / 05

The lane atlas

Depot-to-site lanes,
surveyed to the hour.

SOURCE: OPFOR LANE SURVEY, 2020–2026 · GREAT-CIRCLE KM, DOOR-TO-DOOR LEADMEAN LEAD DEVIATION ±2.1 H
04 / 05

Enrollment vs. coverage

Demand climbs. Supply
stays one step ahead.

Enrollment (patients)Supply coverage (kits staged)
MO — · ENR — · COV —
STUDY SAMP-201 · 36-MONTH WINDOW · COVERAGE FLOOR 1.12× DEMANDHOVER FOR CROSSHAIR
98.2%Avg. service level
25%Less expired drug guaranteed
165Scenarios modeled
6.5 yrsLongest study window
03 / 03 · Request a demo
See it run. Contact
Unlimited by default Scenarios, seats, and protocols. No per-study fees, no per-seat math.
Guaranteed If OPFOR's plan doesn't project at least 25% less expiry than your plan of record at kickoff, with no stockouts, your first year is free.